In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis

Molecular Therapy

Volumn 11, Issue 6, 2005, Pages 926-931

  Shah, Khalid ^a   Tung, Ching Hsuan ^a   Breakefield, Xandra O ^a   Weissleder, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Apoptosis; Luciferase imaging; TRAIL

Indexed keywords

CAMPTOTHECIN; CASPASE 3; LUCIFERIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOLUMINESCENCE; BYSTANDER EFFECT; CANCER CELL; CELL ACTIVITY; CONTROLLED STUDY; CYTOTOXICITY; DISEASE MODEL; ENZYME ACTIVATION; GLIOMA; HUMAN; HUMAN CELL; IMAGING SYSTEM; IN VIVO STUDY; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; PROTEIN FUNCTION; PROTEIN SECRETION; TREATMENT OUTCOME; TUMOR REGRESSION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASE 3; CASPASES; GENE THERAPY; GENETIC VECTORS; GLIOMA; HUMANS; LUCIFERASES; LUMINESCENT MEASUREMENTS; MEMBRANE GLYCOPROTEINS; MICE; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR BURDEN; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 19444363758     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2005.01.017     Document Type: Article

References (17)

1. D.L. Vaux and S.J. Korsmeyer Cell death in development Cell 96 1999 245-254
2. A.H. Wyllie J.F. Kerr and A.R. Currie Cell death: The significance of apoptosis Int. Rev. Cytol. 68 1980 251-306
3. K.J. Pulkkanen et al. HSV-tk gene therapy for human renal cell carcinoma in nude mice Cancer Gene Ther. 8 2001 529-536
4. S.R. Wiley et al. Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 3 1995 673-682
5. J. Rieger U. Naumann T. Glaser A. Ashkenazi and M. Weller APO2 ligand: A novel lethal weapon against malignant glioma? FEBS Lett. 427 1998 124-128
6. I.F. Pollack M. Erff and A. Ashkenazi Direct stimulation of apoptotic signaling by soluble apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells Clin. Cancer Res. 7 2001 1362-1369
7. K. Shah C.H. Tung K. Yang R. Weissleder and X.O. Breakefield Inducible release of TRAIL fusion proteins from a proapoptotic form for tumor therapy Cancer Res. 64 2004 3236-3242
8. S. Bhaumik and S.S. Gambhir Optical imaging of Renilla luciferase reporter gene expression in living mice Proc. Natl. Acad. Sci. USA 99 2002 377-382
9. K. Shah Y. Tang X. Breakefield and R. Weissleder Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo Oncogene 22 2003 6865-6872
10. J. Rotonda et al. The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis Nat. Struct. Biol. 3 1996 619-625
11. B. Laxman et al. Noninvasive real-time imaging of apoptosis Proc. Natl. Acad. Sci. USA 99 2002 16551-16555
12. A. Ashkenazi and V.M. Dixit Apoptosis control by death and decoy receptors Curr. Opin. Cell Biol. 11 1999 255-260
13. H. Walczak et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo Nat. Med. 5 1999 157-163
14. T.S. Griffith R.D. Anderson B.L. Davidson R.D. Williams T. and L. Ratliff Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis J. Immunol. 165 2000 2886-2894
15. S. Kagawa et al. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene Cancer Res. 61 2001 3330-3338
16. J. Seol et al. Adenovirus-TRAIL can overcome TRAIL resistance and induce a bystander effect Cancer Gene Ther. 10 2003 540-548
17. Y. Saeki C. Fraefel T. Ichikawa X.O. Breakefield and E.A. Chiocca Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome Mol. Ther. 3 2001 591-601